Call Us + 33 1 84 88 31 00

Article R5124-66 of the French Public Health Code

Pharmaceutical establishments and companies are authorised to make donations to legal entities for the purpose of encouraging research or the training of health professionals, subject to prior declaration to the Director General of the Regional Health Agency of the place where the registered office of the beneficiary organisation is located and on condition that the real purpose of these donations is not to provide an individual advantage to a member…

Read More »

Article R5124-67 of the French Public Health Code

Where advertising in favour of a pharmaceutical company or establishment mentions a medicinal product, it is governed by the provisions of sections 1, 2 and 3 of Chapter II of this Title; where it mentions a product or object listed in section 4 of the same chapter, it is governed by the provisions of that section. The provisions of the previous paragraph do not apply to scientific, technical or financial…

Read More »

Article R5124-68 of the French Public Health Code

In order to carry out the activities listed in the first paragraph of article L. 5124-1, within the limits defined by the present section, public health establishments which meet the condition set out in article L. 5124-9, create one or more pharmaceutical establishments within their walls, by decision of their board of directors. They must obtain the authorisation referred to in article L. 5124-3 for these establishments. Subject to the…

Read More »

Article R5124-69 of the French Public Health Code

The activities of pharmaceutical establishments managed by public health establishments may only concern medicinal products that meet public health needs that are not already satisfied by medicinal products available in France and benefiting from the marketing authorisation provided for in article L. 5121-8 or the early access authorisation or compassionate access authorisation referred to in article L. 5121-12 and II of article L. 5121-12-1. The content of the annual report…

Read More »

Article R5124-70 of the French Public Health Code

In support of the application for authorisation provided for in article L. 5124-3, public health establishments must prove that they were manufacturing medicinal products industrially on 31 December 1991 and specify the nature and quantities of medicinal products manufactured annually.

Read More »

Article R5124-71 of the French Public Health Code

In each of the public health establishments mentioned in article R. 5124-68, the pharmaceutical establishment or establishments are placed under the responsibility of a pharmacist in charge within the meaning of the second paragraph of article L. 5124-2. To this end, the pharmaceutical establishment(s) is/are organised into business units or internal structures of such a unit, other than functional units.

Read More »

Article R5124-73 of the French Public Health Code

Where a public health care institution sets up several pharmaceutical establishments, each of these establishments is placed under the control of a delegated pharmacist who ensures compliance with the provisions of this section under the authority of the pharmacist in charge. Where the pharmacist in charge performs his duties in one of the pharmaceutical establishments, the appointment of a delegated pharmacist is not compulsory in that establishment. The delegate pharmacist…

Read More »

Article R5124-74 of the French Public Health Code

The declaration provided for in Article L. 5124-20 shall be sent to the Agence nationale de sécurité du médicament et des produits de santé by the person carrying out the brokering activity or by the legal representatives of the company by any means enabling receipt to be acknowledged. The declaration includes administrative information relating to the company, including the name of the legal representatives of the company or, if the…

Read More »

Article R5124-75 of the French Public Health Code

In the event of non-compliance with the obligations set out in article L. 5124-20 and in this chapter, which may be identified following an inspection, the Director General of the Agency may prohibit the brokering activity for a maximum period of six months. Except in cases of urgency, the decision to prohibit practice may only be taken after the person carrying out the activity of brokering medicinal products has been…

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.